Effects of an Exercise Intervention in Frail Older Patients with Chronic Obstructive Pulmonary Disease Hospitalized due to an Exacerbation: A Randomized Controlled Trial

COPD. 2017 Feb;14(1):37-42. doi: 10.1080/15412555.2016.1209476. Epub 2016 Aug 11.

Abstract

The objective of this study was to determine whether an exercise intervention using a pedal exerciser is able to reduce disability in frail older patients with chronic obstructive pulmonary disease (COPD) during hospitalization due to an acute exacerbation. This study was a randomized, single-blind clinical trial. Fifty-eight frail older patients admitted to hospital due to an acute exacerbation of COPD (AECOPD) were included in this study. All patients received standard medical and pharmacological care. Patients assigned to the intervention group also received an exercise intervention. The main outcome measures were balance, muscle strength, and exercise capacity. Significant between-group differences were found in muscle strength (p = 0.028) and balance (p = 0.013) after the intervention. All the variables improved significantly (p < 0.05) in the exercise intervention group. In the intervention group, the mean difference in muscle strength between baseline and discharge was 10.47 N. Balance also improved, showing a mean difference of 7.56 seconds on the right leg and 6.57 seconds on the left leg. Exercise capacity improved as well, with a difference of 4.97 stands between baseline and discharge. All the variables showed impairment in the control group. In conclusion, an exercise intervention using a pedal exerciser during the hospital stay of frail elderly patients with an AECOPD improves muscle strength, balance, and exercise capacity.

Trial registration: ClinicalTrials.gov NCT01826682.

Keywords: Disability; elderly; frailty; hospitalization.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Adrenal Cortex Hormones / therapeutic use
  • Aged
  • Aged, 80 and over
  • Bronchodilator Agents / therapeutic use
  • Disease Progression*
  • Exercise Therapy* / instrumentation
  • Exercise Tolerance
  • Female
  • Frail Elderly*
  • Hospitalization
  • Humans
  • Length of Stay
  • Male
  • Muscle Strength
  • Oxygen Inhalation Therapy
  • Postural Balance
  • Pulmonary Disease, Chronic Obstructive / therapy*
  • Single-Blind Method
  • Symptom Flare Up

Substances

  • Adrenal Cortex Hormones
  • Bronchodilator Agents

Associated data

  • ClinicalTrials.gov/NCT01826682